Study2018

Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice

Che H, Li Q, Zhang T, Zhang T, Wang D, Yang L, Xu J, Yanagita T, Xue C, Chang Y, Wang Y

Journal of agricultural and food chemistry · 92 citations

How it was studied

Design
Animal study (classified by our AI screen)
Studied in
Animals
Main outcome
Health markers and function

Who paid for it

Funding
Independent funding
Government
National Natural Science Foundation of China
Government
Ministry of Education of the People's Republic of China
Government
Japan Society for the Promotion of Science
Government
Government of Shandong Province
Government
Shandong Province
Government
Ministry of Education of the People's Republic of China
Grants
National Natural Science Foundation of China (U1606403); Ministry of Education of the People's Republic of China (201762028); National Natural Science Foundation of China (31330060); Japan Society for the Promotion of Science (16K00890); Government of Shandong Province (U1606403)

Based on 6 listed funder(s).

Publication

Published
2018-04-25 · J Agric Food Chem · vol. 66 · issue 19 · pp. 4948–4957
Publisher
American Chemical Society
Cited
150 citations · more than 97% of similar papers · 4.7× the field average
Impact
Top 10% most cited in its field
References
30 works
Access
Paywalled
Research areas
Antioxidant Activity and Oxidative Stress · Coenzyme Q10 studies and effects · Fatty Acid Research and Health
Keywords
Neuroinflammation, Docosahexaenoic acid, Astaxanthin, Morris water navigation task, Oxidative stress, Senile plaques, Pharmacology, Genetically modified mouse, Chemistry, Pathogenesis, Alzheimer's disease, Medicine, Transgene, Biochemistry, Endocrinology, Internal medicine, Fatty acid, Polyunsaturated fatty acid, Hippocampus, Disease
MeSH
animals, mice, transgenic, humans, mice, alzheimer disease, xanthophylls, docosahexaenoic acids, amyloid beta-protein precursor, learning, memory, acylation, female, male, presenilin-1

10 authors

From CN, JP

  • Hongxia CheOcean University of China
  • Qian LiOcean University of China
  • Tiantian ZhangOcean University of China
  • Dandan WangOcean University of China
  • Lu YangOcean University of China
  • Jie XuOcean University of China

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with the characteristics of senile plaques, neuroinflammation, neurofibrillary tangles, and destruction of synapse structure stability. Previous studies have verified the protective effects of astaxanthin (AST). However, whether synthesized docosahexaenoic-acid-acylated AST diesters (AST-DHA) could delay AD pathogenesis remains unclear. In the present study, APP/PSEN1 (APP/PS1) double-transgenic mice were administrated with AST and AST-DHA for 2 months. The results of radial 8-arm maze and Morris water maze tests showed that AST-DHA exerted more significant effects than AST in enhancing learning and memory levels of APP/PS1 mice. Further mechanical studies suggested that AST-DHA was superior to AST in regulating the parameters of oxidative stress, reducing tau hyperphosphorylation, suppressing neuroinflammation, and regulating inflammasome expression and activation in APP/PS1 mice. The findings suggested that AST-DHA attenuated cognitive disorders by reducing pathological features in APP/PS1 mice, suggesting that AST-DHA might be a potential therapeutic agent for AD.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.